The importance of probiotics in pig production is widely recognized. However, the precise role of probiotics in regulating the gut microbiota of piglets has not been assessed extensively. Therefore, we intend to examine whether suckling pigs ingesting with synthetic milk (SM) and probiotics along with mother milk has a carryover effect on its growth and gut health at the post-weaning stage. A total of 40 [Duroc× (Yorkshire× Landrace)] neonates with an initial BW of 1.49 ± 0.28 kg were assigned to one of two treatments groups: control (CON) and treatment (TRT). Control group piglets were nourished with synthetic milk, while TRT group piglets were nourished SM with (1 × 109 CFU/g) Lactobacillus sp. probiotics. The treatment group piglets showed higher (p < 0.05) body weight and daily gain at week 3 than the CON group piglets. 16S metagenome sequencing showed average demultiplexed reads and denoised reads counts of 157,399 and 74,945, respectively. The total ASV taxonomy number classified with a confidence threshold > 70% (default) on sequence alignment with the SILVA v138 reference database was 4,474. During week 1, Escherichia-Shigella, Clostridium sensu stricto 1, and Bacteroides were confirmed as the major dominant bacterial genera in both the groups at the genus level. However, during week 2, the relative proportion of Escherichia-Shigella, Clostridium sensu stricto 1, and Proteobacteria was decreased, while that of Lactobacillus and Bacteroidota was increased in pigs receiving the probiotic supplement. During weeks 2 and 3, Firmicutes, Proteobacteria, and Bacteroidota phyla were dominant in both groups. During week 6, the relative proportion of Proteobacteria was slightly increased in both groups. Furthermore, Prevotella was confirmed as the major dominant bacterial genus in both groups during weeks 3 and 6. This study suggests that nourishing neonatal piglets with synthetic milk and Lactobacillus sp. probiotics from birth to 21 days would be beneficial to enhance the gut health of piglets and to overcome post-weaning mortality.
We have conducted this experiment to evaluate a new exogenous protease in finishing pigs' growth performance, nutrient digestibility, gas emission, blood profiles, and meat quality. A total of 200 pigs of 52.15 ± 2.31 kg average body weight (BW) were divided into four dietary treatments named as: CON, basal diet; TRT1, basal diet + 0.05% protease; TRT2, basal diet + 0.1% protease; TRT3, basal diet + 1.5% protease. Each treatment consisted of 10 pens, where five pigs were allotted to each pen according to their body weight and sex. The dietary treatments were allotted to the pens in a randomized block design. During this 10‐week‐long experiment, BW, average daily gain (ADG), average daily feed intake (ADFI), and gain to feed ratio (G:F) were calculated for Week 0–5, Week 6–10, and the overall period. During Week 6–10, ADG was higher in TRT2 and TRT3 than in the CON and TRT1 groups. At the same time, a linear increase was observed in ADG and G:F of the pigs. In addition, the final BW of pigs' was linearly increased by protease supplementation. On Week 10, there was a linear trend of increase (p = 0.0575) in crude protein digestibility and a trend of linear reduction (p = 0.0651) in NH3 gas emission. In blood profile, cortisol presented a linear decrease in both Week 5 (p = 0.251) and Week 10 (p = 0.0585). In addition, increasing doses of protease showed a trend of linear increase (p = 0.0592) in creatinine, whereas linear reduction was observed in the concentration of epinephrine (p = 0.0636) and norepinephrine (p = 0.0167) during Week 10. In conclusion, protease supplementation helped in improving daily gain in finishing pigs through protein digestibility with associated reduction of ammonia emission and blood stress hormones.
IntroductionThe objective of this study was to investigate the effects of dietary supplementation of tributyrin and anise mixture (TA) on growth performance, apparent nutrient digestibility, fecal noxious gas emission, fecal score, jejunal villus height, hematology parameters, and fecal microbiota of weaned pigs.MethodsA total of 150 21-day-old crossbred weaned pigs [(Landrace × Yorkshire) × Duroc] were used in a randomized complete block design experiment. All pigs were randomly assigned to 3 groups based on the initial body weight (6.19 ± 0.29 kg). Each group had 10 replicate pens with 5 pigs (three barrows and two gilts) per pen. The experimental period was 42 days and consisted of 3 phases (phase 1, days 1–7; phase 2, days 8–21; phase 3, days 22–42). Dietary treatments were based on a corn-soybean meal-basal diet and supplemented with 0.000, 0.075, or 0.150% TA.Results and discussionWe found that dietary supplementation of graded levels of TA linearly improved body weight, body weight gain, average daily feed intake, and feed efficiency (P < 0.05). TA supplementation also had positive effects on apparent dry matter, crude protein, and energy digestibility (P < 0.05) and jejunal villus height (P < 0.05). The emission of ammonia from feces decreased linearly with the dose of TA increased (P < 0.05). Moreover, TA supplementation was capable to regulate the fecal microbiota diversity, manifesting in a linearly increased Chao1 index and observed species and a linearly decreased Pielou's index (P < 0.05). The abundance of Lactobacillus reuteri, Lactobacillus amylovorus, Clostridium butyricum were increased, while the abundance of Prevotella copri was decreased, by treatment (P < 0.05). Therefore, we speculated that TA supplementation would improve growth performance and reduce fecal ammonia emission through improving nutrient digestibility, which was attributed to the increase of jejunal villus height and the regulation of fecal microbiota.
Recently, phytogenic feed additives containing flavonoids, essential oils and phenols are getting more attention as they have antimicrobial, anti-inflammatory, and digestibility aiding abilities. Flavonoids have proved their abilities in reducing environmental stress along with activating immune responses. These positive impacts can be used to bring an improved growth performance in broilers, so we aimed to evaluate the effect of flavonoid supplementation to a low protein diet on growth performance, nutrient digestibility, excreta bacterial count and excreta gas emission in broilers. In total 800 one-day-old Ross 308 broilers (average body weight of 42.90±1.43 g) were divided randomly into 1 of 4 dietary treatments. Each treatment had 10 replicate pens with 20 chickens. Treatment diets were HCP (High protein diet), basal diet; LCP (Low protein diet), basal diet – 2.5% protein; TRT1, LCP + 0.025 flavonoid; TRT2, LCP + 0.050% flavonoid. Experimental diets were provided to broilers from d 8 to 35. HCP, LCP supplemented with flavonoid showed greater (P < 0.05) body weight gain (BWG) than the low protein diet (LCP) without flavonoid supplementation during d 8 to 21, and in the overall experiment. However, feed conversion ratio (FCR) of HCP group was reduced (P < 0.05) than the LCP group during d 8 to 21 and in overall period. Increasing level of flavonoid supplementations brought a linear increase in BWG during d 8 to 21 (P = 0.0141), and overall period (P = 0.0153). Increasing doses of flavonoid showed a tendency of gradual increase (P = 0.0702) in dry matter (DM) digestibility in broilers. Lactobacillus, E. coli and Salmonella counts in excreta samples of experimental groups showed no significant difference (P > 0.05). Flavonoid supplementation (0.050%) in low protein diet reduced (P < 0.05) drip loss in breast muscle than the low protein diet with 0% flavonoid supplementation. In short, flavonoid supplementation to a low protein diet recovered the body weight gain through better digestion broilers
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.